Sponsor Pipeline

Aspera Biomedicines, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07250646 A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid… Secondary AML Recruiting
Disease Areas
Acute Myeloid Leukemia (AML) (1) Myelofibrosis (1)
Get alerts when Aspera Biomedicines, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free